Foundation Medicine (FMI) Misses Q2 EPS by 1c

Foundation Medicine (NASDAQ: FMI) reported Q2 EPS of ($0.49), $0.01 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $14.5 million versus the consensus estimate of $13.39 million.

For earnings history and earnings-related data on Foundation Medicine (FMI) click here.

You May Also Be Interested In

• EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
• Intellinetics, Inc. (INLX) Misses Q2 EPS by 17c
• GEE Group (JOB) Reports Q3 EPS of $0.01